|Articles|October 7, 2021
OTC Pearl of the Day: Vitamin B1
Author(s)Saro Arakelians, PharmD
People with poor diet, cancer, morning sickness during pregnancy, bariatric surgery, and hemodialysis are at risk of thiamin deficiency.
Advertisement
OTC/Lifestyle Pearl of the Day: Vitamin B1
Indication: Thiamine (vitamin B1) is needed for the breakdown of carbohydrates.
Insight:
- Lack of thiamine may lead to a condition called beriberi. Signs of beriberi include loss of appetite, constipation, muscle weakness, pain or tingling in arms or legs, and possible swelling of feet or lower legs.
- People with poor diet,
cancer ,morning sickness during pregnancy, bariatric surgery, and hemodialysis are at risk of thiamin deficiency. - Some conditions that may increase the need for thiamine include alcoholism burns, diarrhea (continuing), fever (continuing), illness (continuing), intestinal disease, liver disease, overactive thyroid, and stress.
- Thiamine is found in various foods, including cereals (whole-grain and enriched), peas, beans, nuts, and meats (especially pork and beef). Some thiamine in foods is lost with cooking.
- Tea and
coffee contain tannins, chemicals that may interact with thiamine, making it harder to absorb. - In the United States, the
recommended daily allowance trusted source of thiamine taken by mouth is 1.2 mg for males and 1.1 mg for females over 18 years of age. Pregnant or breastfeeding women of any age should consume 1.4 mg each day.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- IMS 2025: Shifting Immunotherapies to Outpatient Care for Multiple Myeloma
September 19th 2025
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
Effectively Managing Immunizations in the Long-Term Care Setting
5